Fungal diagnostics: Review of commercially available methods

Methods in Molecular Biology

Volumn 968, Issue , 2013, Pages 25-54

  Marcos, Javier Yugueros ^a   Pincus, David H ^a  

^a BIOMÉRIEUX   (France)

Author keywords

Antibody based test; Antigen based test; Chromogenic media; Commercial test; Direct examination; Fungal diagnostics; Molecular biology; Nucleic acid probes; Yeast identi fication

Indexed keywords

CANDIDA; CANDIDA ALBICANS; CANDIDA PARATROPICALIS; CULTURE MEDIUM; DIAGNOSTIC PROCEDURE; HISTOPATHOLOGY; HUMAN; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CULTURE TECHNIQUE; DIAGNOSTIC TEST; FUNGUS; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOASSAY; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MICROBIOLOGY; MOLECULAR BIOLOGY;

FUNGUS ANTIBODY; FUNGUS ANTIGEN;

ANIMALS; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CULTURE TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; FUNGI; HUMANS; IMMUNOASSAY; MOLECULAR BIOLOGY; MYCOSES;

MLCS; MLOWN;

EID: 84878663417     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-257-5_2     Document Type: Review

References (151)

1. Fridkin SK (2005) The changing face of fungal infections in health care settings. Clin Infect Dis 41:1455-60
2. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327-360
3. Chandler FW, Kaplan W, Ajello L (1980) Color atlas and text of the histopathology of mycotic diseases. Year Book Medical Publishers, Chicago
4. Monheit JE, Cowan DF, Moore DG (1984) Rapid detection of fungi in tissue using calco fl uor white and fl uorescence microscopy. Arch Pathol Lab Med 108:616-618
5. Nolte FS, Williams JM, Jerris RC, Morello JA, Leitch CD, Matushek S, Schwabe LD, Dorigan F, Kocka FE (1993) Multicenter clinical evaluation of a continuous monitoring blood culture system using fl uorescent-sensor technology (BACTEC 9240). J Clin Microbiol 31:552-557
6. Thorpe TC, Wilson ML, Turner JE, DiGuiseppi JL, Willert M, Mirrett S, Reller LB (1990) BacT/Alert: an automated colorimetric microbial detection system. J Clin Microbiol 28:1608-1612
7. Mirrett S, Hanson KE, Reller LB (2007) Controlled clinical comparison of VersaTREK and BacT/ALERT blood culture systems. J Clin Microbiol 45:299-302
8. Taschdjian CL, Burchall JJ, Kozinn PJ (1960) Rapid identi fication of Candida albicans by filamentation on serum and serum substitutes. Am J Dis Child 99:212-215
9. Crist AE Jr, Dietz TJ, Kampschroer K (1996) Comparison of the MUREX C. albicans, Albicans-Sure, and BactiCard Candida test kits with the germ tube test for presumptive identi fication of Candida albicans . J Clin Microbiol 34:2616-2618
10. Heelan JS, Siliezar D, Coon K (1996) Comparison of rapid testing methods for enzyme production with the germ tube method for presumptive identi fication of Candida albicans . J Clin Microbiol 34:2847-2849
11. Carrillo-Muñoz AJ, Quindós G, Cárdenes CD, Alonso-Vargas R, Brió S, Arévalo P, Pemán J, Estivill D, Pontón J (2003) Performance of Bacticard Candida compared with the germ tube test for the presumptive identi fication of Candida albicans . Mycoses 46:467-470
12. Cárdenes CD, Carrillo-Muñoz AJ, Arias A, Rodríguez-Alvarez C, Torres-Lana A, Sierra A, Arévalo MP (2004) Comparative evaluation of four commercial tests for presumptive identi fication of Candida albicans . J Microbiol Methods 59:293-297
13. Fenn JP, Segal H, Blevins L, Fawson S, Newcomb-Gayman P, Carroll KC (1996) Comparison of the Murex Candida albicans CA50 test with germ tube production for identi fication of C. albicans. Diagn Microbiol Infect Dis 24:31-35
14. Baalham T, Brown A, Dunsmuir R, Shankland GS, Blackman M (2005) Comparative evaluation of a new biochemical test kit for the presumptive identi fication of Candida albicans . 15th European Congress of Clinical Microbiology and Infectious Diseases Copenhagen /Denmark. Abstract number: 1134-01-304 http://www.blackwellpublishing. com/eccmid15/abstract.asp?id=36567 Accessed 19 July 2011
15. Staib F (1962) Cryptococcus neoformans und Guizotia abyssinica (syn. G. oleifera D.C.). Farbreaktion für Cr. neoformans . Z Hyg Infektionskr Med Mikrobiol Immunol Virol 148:466-475
16. Denning DW, Stevens DA, Hamilton JR (1990) Comparison of Guizotia abyssinica seed extract (birdseed) agar with conventional media for selective identi fication of Cryptococcus neoformans in patients with acquired immunode ficiency syndrome. J Clin Microbiol 28:2565-2567
17. Fleming WH, Hopkins JM, Land GA (1977) New culture medium for the presumptive identi ficaion of Candida albicans and Cryptococcus neoformans . J Clin Microbiol 5: 236-243
18. Roberts GD, Horstmeier CD, Land GA, Foxworth JH (1978) Rapid urea broth test for yeasts. J Clin Microbiol 7:584-588
19. Zimmer BL, Roberts GD (1979) Rapid selective urease test for presumptive identi fication of Cryptococcus neoformans . J Clin Microbiol 10:380-381
20. Freydière AM, Robert R, Ploton C, Marot-Leblond A, Monerau F, Vandenesch F (2003) Rapid identi fication of Candida glabrata with a new commercial test, GLABRATA RTT. J Clin Microbiol 41:3861-3963
21. Freydière AM, Perry JD, Faure O, Willinger B, Tortorano AM, Nicholson A, Peman J, Verweij PE (2004) Routine use of a commercial test, GLABRATA RTT, for rapid identi fication of Candida glabrata in six laboratories. J Clin Microbiol 42:4870-4872
22. Pemán J, Aparisi N, García-Esteban C, Gobernado M (2004) Rapid identi fication of Candida glabrata using a new commercial kit. Rev Iberoam Micol 21:82-84
23. Willinger B, Wein S, Hirschl AM, Rotter ML, Mana fiM (2005) Comparison of a new commercial test, GLABRATA RTT, with a dipstick test for rapid identi fication of Candida glabrata . J Clin Microbiol 43:499-501
24. Fenn JP, Billetdeaux E, Segal H, Skodack-Jones L, Padilla PE, Bale M, Carroll K (1999) Comparison of four methodologies for rapid and cost-effective identi fication of Candida glabrata . J Clin Microbiol 37: 3387-3389
25. Lopez J, Dalle F, Mantelin P, Moiroux P, Nierlich AC, Pacot A, Cuisenier B, Vagner O, Bonnin A (2001) Rapid identi fication of Candida glabrata based on trehalose and sucrose assimilation using Rosco diagnostic tablets. J Clin Microbiol 39:1172-1174
26. Freydière A-M, Parant F, Noel-Baron F, Crepy M, Treny A, Raberin H, Davidson A, Odds FC (2002) Identi fication of Candida glabrata by a 30-second trehalase test. J Clin Microbiol 40:3602-3605
27. Murray MP, Zinchuk R, Larone DH (2005) CHROMagar Candida as the sole primary medium for isolation of yeasts and as a source medium for the rapid-assimilationof-trehalose test. J Clin Microbiol 43: 1210-1212
28. Odds FC, Hanson MF, Davidson AD, Jacobsen MD, Wright P, Whyte JA, Gow NA, Jones BL (2007) One year prospective survey of Candida bloodstream infections in Scotland. J Med Microbiol 56:1066-1075
29. Orenga S, James AL, Mana fiM, Perry JD, Pincus DH (2009) Enzymatic substrates in microbiology. J Microbiol Methods 79: 139-155
30. Perry JD, Freydière AM (2007) The application of chromogenic media in clinical microbiology. J Appl Microbiol 103:2046-2055
31. Ghelardi E, Pichierri G, Castagna B, Barnini S, Tavanti A, Campa M (2008) Ef ficacy of Chromogenic Candida Agar for isolation and presumptive identi fication of pathogenic yeast species. Clin Microbiol Infect 14: 141-147
32. Sendid B, François N, Standaert A, Dehecq E, Zerimech F, Camus D, Poulain D (2007) Prospective evaluation of the new chromogenic medium CandiSelect 4 for differentiation and presumptive identi fication of the major pathogenic Candida species. J Med Microbiol 56:495-499
33. Odds FC, Bernaerts R (1994) CHROMagar Candida, a new differential isolation medium for presumptive identi fication of clinically important Candida species. J Clin Microbiol 32:1923-1929
34. Powell HL, Sand CA, Rennie RP (1998) Evaluation of CHROMagar Candida for presumptive identi fication of clinically important Candida species. Diagn Microbiol Infect Dis 32:201-204
35. Baumgartner C, Freydière AM, Gille Y (1996) Direct identi fication and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates. J Clin Microbiol 34:454-456
36. Fricker-Hidalgo H, Vandapel O, Duchesne MA, Mazoyer MA, Monget D, Lardy B, Lebeau B, Freney J, Ambroise-Thomas P, Grillot R (1996) Comparison of the new API Candida system to the ID 32C system for identi fication of clinically important yeast species. J Clin Microbiol 34:1846-1848
37. Bernal S, Martín Mazuelos E, Chávez M, Coronilla J, Valverde A (1998) Evaluation of the new API Candida system for identi fication of the most clinically important yeast species. Diagn Microbiol Infect Dis 32:217-221
38. Buchaille L, Freydière AM, Guinet R, Gille Y (1998) Evaluation of six commercial systems for identi fication of medically important yeasts. Eur J Clin Microbiol Infect Dis 17:479-488
39. Campbell CK, Davey KG, Holmes AD, Szekely A, Warnock DW (1999) Comparison of the API Candida system with the AUXACOLOR system for identi fication of common yeast pathogens. J Clin Microbiol 37:821-823
40. Paugam A, Benchetrit M, Fiacre A, Tourte-Schaefer C, Dupouy-Camet J (1999) Comparison of four commercialized biochemical systems for clinical yeast identi fication by colour-producing reactions. Med Mycol 37:11-17
41. Buesching WJ, Kurek K, Roberts GD (1979) Evaluation of the modi fied API 20C system for identi fication of clinically important yeasts. J Clin Microbiol 9:565-569
42. Land GA, Harrison BA, Hulme KL, Cooper BH, Byrd JC (1979) Evaluation of the new API 20C strip for yeast identi fication against a conventional method. J Clin Microbiol 10:357-364
43. Bergan T, Hollum AB, Vangdal M (1982) Evaluation of four commercial biochemical test systems for identi fication of yeasts. Eur J Clin Microbiol 1:217-222
44. Schuffenecker I, Freydière A, de Montclos H, Gille Y (1993) Evaluation of four commercial systems for identi fication of medically important yeasts. Eur J Clin Microbiol Infect Dis 12:255-260
45. Willemsen M, Breynaert J, Lauwers S (1997) Comparison of Auxacolor with API 20 C Aux in yeast identi fication. Clin Microbiol Infect 3:369-375
46. Ramani R, Gromadzki S, Pincus DH, Salkin IF, Chaturvedi V (1998) Ef ficacy of API 20C and ID 32C systems for identi fication of common and rare clinical yeast isolates. J Clin Microbiol 36:3396-3398
47. Sand C, Rennie RP (1999) Comparison of three commercial systems for the identi fication of germ-tube negative yeast species isolated from clinical specimens. Diagn Microbiol Infect Dis 33:223-229
48. Wadlin JK, Hanko G, Stewart R, Pape J, Nachamkin I (1999) Comparison of three commercial systems for identi fication of yeasts commonly isolated in the clinical microbiology laboratory. J Clin Mcrobiol 37:1967-1970
49. Gündes SG, Gulenc S, Bingol R (2001) Comparative performance of Fungichrom I, Candifast and API 20C Aux systems in the identi fication of clinically signi ficant yeasts. J Med Microbiol 50:1105-1110
50. Milan EP, Malheiros ES, Fischman O, Colombo AL (1997) Evaluation of the AUXACOLOR system for the identi fication of clinical yeast isolates. Mycopathologia 137:153-157
51. Sheppard DC, deSouza E, Hashmi Z, Robson HG, René P (1998) Evaluation of the Auxacolor system for biochemical identi fication of medically important yeasts. J Clin Microbiol 36:3726-3727
52. Romney MG, Bryce EA, Rennie RP, Sand CA (2000) Rapid identi fication of clinical yeast isolates using the colorimetric AUXACOLOR system. Diagn Microbiol Infect Dis 36:137-138
53. Latouche GN, Daniel HM, Lee OC, Mitchell TG, Sorrell TC, Meyer W (1997) Comparison of use of phenotypic and genotypic characteristics for identi fication of species of the anamorph genus Candida and related teleomorph yeast species. J Clin Microbiol 35:3171-3180
54. Marklein G, Josten M, Klanke U, Müller E, Horré R, Maier T, Wenzel T, Kostrzewa M, Bierbaum G, Hoerauf A, Sahl HG (2009) Matrix-assisted laser desorption ionizationtime of fl ight mass spectrometry for fast and reliable identi fication of clinical yeast isolates. J Clin Microbiol 47:2912-2917
55. Kitch TT, Jacobs MR, McGinnis MR, Appelbaum PC (1996) Ability of RapID Yeast Plus System to identify 304 clinically signi ficant yeasts within 5 hours. J Clin Microbiol 34:1069-1071
56. Espinel-Ingroff A, Stockman L, Roberts G, Pincus D, Pollack J, Marler J (1998) Comparison of RapID yeast plus system with API 20C system for identi fication of common, new, and emerging yeast pathogens. J Clin Microbiol 36:883-886
57. Heelan JS, Sotomayor E, Coon K, D'Arezzo JB (1998) Comparison of the rapid yeast plus panel with the API20C yeast system for identi fication of clinically signi ficant isolates of Candida species. J Clin Microbiol 36: 1443-1445
58. Sanguinetti M, Porta R, Sali M, La Sorda M, Pecorini G, Fadda G, Posteraro B (2007) Evaluation of VITEK 2 and RapID Yeast Plus systems for yeast species identi fication: experience at a large clinical microbiology laboratory. J Clin Microbiol 45:1343-1346
59. Bowman PI, Ahearn DG (1975) Evaluation of the Uni-Yeast-Tek kit for the identi fication of medically important yeasts. J Clin Microbiol 2:354-358
60. Bowman PI, Ahearn DG (1976) Evaluation of commercial systems for the identi fication of clinical yeast isolates. J Clin Microbiol 4:49-53
61. Cooper BH, Johnson JB, Thaxton ES (1978) Clinical evaluation of the Uni-Yeast-Tek system for rapid presumptive identi fication of medically important yeasts. J Clin Microbiol 7:349-355
62. Salkin IF, Land GA, Hurd NJ, Goldson PR, McGinnis MR (1987) Evaluation of YeastIdent and Uni-Yeast-Tek yeast identi fication systems. J Clin Microbiol 25: 624-627
63. McGinnis MR, Molina TC, Pierson DL, Mishra SK (1996) Evaluation of the Biolog MicroStation system for yeast identi fication. J Med Vet Mycol 34:349-352
64. Land GA, Salkin IF, El-Zaatari M, McGinnis MR, Hashem G (1991) Evaluation of the Baxter-MicroScan 4-hour enzyme-based yeast identi fication system. J Clin Microbiol 29: 718-722
65. St Germain G, Beauchesne D (1991) Evaluation of the MicroScan rapid yeast identi fication panel. J Clin Microbiol 29:2296-2299
66. Riddle DL, Giger O, Miller L, Hall GS, Woods GL (1994) Clinical comparison of the Baxter MicroScan yeast identi fication panel and the Vitek Yeast Biochemical Card. Am J Clin Pathol 101:438-442
67. Crist AE Jr, Johnson LM, Burke PJ (1996) Evaluation of the Microbial Identi fication System for identi fication of clinically isolated yeasts. J Clin Microbiol 34:2408-2410
68. Kellogg JA, Bankert DA, Chaturvedi V (1998) Limitations of the current Microbial Identi fication System for identi fication of clinical yeast isolates. J Clin Microbiol 36: 1197-1200
69. Kellogg JA, Bankert DA, Chaturvedi V (1999) Variation in Microbial Identi fication System accuracy for yeast identi fication depending on commercial source of Sabouraud dextrose agar. J Clin Microbiol 37: 2080-2083
70. Oblack DL, Rhodes JC, Martin WJ (1981) Clinical evaluation of the AutoMicrobic system Yeast Biochemical Card for rapid identi fication of medically important yeasts. J Clin Microbiol 13:351-355
71. Land G, Stotler R, Land K, Staneck J (1984) Update and evaluation of the AutoMicrobic yeast identi fication system. J Clin Microbiol 20:649-652
72. el-Zaatari M, Pasarell L, McGinnis MR, Buckner J, Land GA, Salkin IF (1990) Evaluation of the updated Vitek yeast identifi cation data base. J Clin Microbiol 28: 1938-1941
73. Fenn JP, Segal H, Barland B, Denton D, Whisenant J, Chun H, Christofferson K, Hamilton L, Carroll K (1994) Comparison of updated Vitek Yeast Biochemical Card and API 20C yeast identi fication systems. J Clin Microbiol 32:1184-1187
74. Dooley DP, Beckius ML, Jeffrey BS (1994) Misidenti fication of clinical yeast isolates by using the updated Vitek Yeast Biochemical Card. J Clin Microbiol 32:2889-2892
75. Aubertine CL, Rivera M, Rohan SM, Larone DH (2006) Comparative study of the new colorimetric VITEK 2 yeast identi fication card fl uorometric card and of CHROMagar Candida as a source medium with the new card. J Clin Microbiol 44:227-228
76. Loïez C, Wallet F, Sendid B, Courcol RJ (2006) Evaluation of VITEK 2 colorimetric cards versus fl uorimetric cards for identi fication of yeasts. Diagn Microbiol Infect Dis 56: 455-457
77. Hata DJ, Hall L, Fothergill AW, Larone DH, Wengenack NL (2007) Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identi fication versus the older card. J Clin Microbiol 45:1087-1092
78. Valenza G, Strasen J, Schafer F, Frosch M, Kurzai O, Abele-Horn M (2008) Evaluation of new colorimetric Vitek 2 yeast identi fication card by use of different source media. J Clin Microbiol 46:3784-3787
79. Vijgen S, Nys S, Naesens R, Magerman K, Boel A, Cartuyvels R (2011) Comparison of Vitek identi fication and antifungal susceptibility testing methods to DNA sequencing and Sensititre YeastOne antifungal testing. Med Mycol 49:107-110
80. Hasyn JJ, Buckley HR (1982) Evaluation of the AutoMicrobic system for identi fication of yeasts. J Clin Microbiol 16:901-904
81. Pfaller MA, Preston T, Bale M, Koontz FP, Body BA (1988) Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identi fication of clinical yeast isolates. J Clin Microbiol 26:2054-2058
82. Quiles-Melero I, García-Rodriguez J, Romero-Gómez MP, Gómez-Sánchez P, Mingorance J (2011) Rapid identi fication of yeasts from positive blood culture bottles by pyrosequencing. Eur J Clin Microbiol Infect Dis 30:21-24
83. Fukazawa Y (1989) Antigenic structure of Candida albicans . Immunochemical basis of the serologic speci ficity of the mannans in yeasts. Immunol Ser 47:37-62
84. Bille J (2010) New nonculture-based methods for the diagnosis of invasive candidiasis. Curr Opin Crit Care 16:460-464
85. Oliveri S, Trovato L, Betta P, Romeo MG, Nicoletti G (2008) Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin Microbiol Infect 14:391-393
86. Platelia™ Candida AB/AC/AK (2009) Bio-Rad instructions for use. Accessed 01 May 2011
87. Alam FF, Mustafa AS, Khan ZU (2007) Comparative evaluation of (1, 3)-b -D-glucan, mannan and anti-mannan antibodies, and Candida species-speci fic snPCR in patients with candidemia. BMC Infect Dis 7:103-111
88. Arendrup MC, Bergmann OJ, Larsson L, Nielsen HV, Jarløv JO, Christensson B (2010) Detection of candidaemia in patients with and without underlying hematological disease. Clin Microbiol Infect 16:855-862
89. Sendid B, Caillot D, Baccouch-Humbert B, Klingspor L, Grandjean M, Bonnin A, Poulain D (2003) Contribution of the Platelia Candida-speci fic antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J Clin Microbiol 41:4551-4558
90. Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C, Third European Conference on Infections in Leukemia Group (2010) The use of mannan antigen and antimannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care 14:R222
91. Downey LC, Smith PB, Benjamin DK, Cohen-Wolkowiez M (2010) Recent advances in the detection of neonatal Candidiasis. Curr Fungal Infect Rep 4:17-22
92. Lunel FM, Mennink-Kersten MA, Ruegebrink D, van der Lee HA, Donnelly JP, Blijlevens NM, Verweij PE (2009) Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy. Diagn Microbiol Infect Dis 64:408-15
93. Wulf GG, Conradi I, Rüchel R (2004) Diagnostic value of antibody detection against Candida germ tube antigens in a patient with hepatosplenic candidosis. Mycoses 47(Suppl 1):11-14
94. Mitsutake K, Miyazaki T, Tashiro T, Yamamoto Y, Kakeya H, Otsubo T, Kawamura S, Hossain MA, Noda T, Hirakata Y, Kohno S (1996) Enolase antigen, mannan antigen, Cand-Tec antigen, and b -glucan in patients with candidemia. J Clin Microbiol 34: 1918-1921
95. Mori T, Matsumura M (1999) Clinical evaluation of diagnostic methods using plasma and/or serum for three mycoses: aspergillosis, candidosis, and pneumocystosis. Nippon Ishinkin Gakkai Zasshi 40:223-230
96. Bär W, Hecker H (2002) Diagnosis of systemic Candida infections in patients of the intensive care unit. Signi ficance of serum antigens and antibodies. Mycoses 45:22-28
97. Pazos C, Moragues MD, Quindós G, Pontón J, Palacio A (2006) Diagnostic potential of (1 → 3)-b -D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients. Rev Iberoam Micol 23:209-215
98. Moragues MD, Ortiz N, Iruretagoyena JR, García-Ruiz JC, Amutio E, Rojas A, Mendoza J, Quindós G, Pontón-San Emeterio J (2004) Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis. Enferm Infecc Microbiol Clin 22:83-88
99. Pemán J, Zaragoza R, Quindós G, Alkorta M, Cuétara MS, Camarena JJ, Ramírez P, Giménez MJ, Martín-Mazuelos E, Linares-Sicilia MJ, Pontón J, The study group Candida albicans Germ Tube Antibody Detection in Critically Ill Patients (CAGTAUCI) (2011) Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients. BMC Infect Dis 11:60-65
100. Zaragoza R, Pemán J, Quindós G, Iruretagoyena JR, Cuétara MS, Ramírez P, Gómez MD, Camarena JJ, Viudes A, Pontón J, On behalf of the study group Candida albicans Germ Tube Antibody Detection in Critically Ill Patients (CAGTAUCI) (2009) Clinical signi ficance of the detection of Candida albicans germ tube-speci fic antibodies in critically ill patients. Clin Microbiol Infect 15:592-595
101. Temstet A, Roux P, Poirot JL, Ronin O, Dromer F (1992) Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies. J Clin Microbiol 30:2544-2550
102. Tanner DC, Weinstein MP, Fedorciw B, Joho KL, Thorpe JJ, Reller L (1994) Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 32:1680-1684
103. Blevins LB, Fenn J, Segal H, Newcomb-Gayman P, Carroll KC (1995) False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps. J Clin Microbiol 33:1674-1675
104. Wilson DA, Sholtis M, Parshall S, Hall GS, Procop GW (2011) False-positive cryptococcal antigen test associated with use of BBL Port-A-Cul transport vials. J Clin Microbiol 49:702-703
105. Heelan JS, Corpus L, Kessimian N (1991) False-positive reactions in the latex agglutination test for Cryptococcus neoformans antigen. J Clin Microbiol 29:1260-1261
106. McFadden DC, Zaragoza O, Casadevall A (2004) Immunoreactivity of cryptococcal antigen is not stable under prolonged incubations in human serum. J Clin Microbiol 42:2786-2788
107. Saha DC, Xess I, Biswas A, Bhowmik DM, Padma MV (2009) Detection of Cryptococcus by conventional, serological and molecular methods. J Med Microbiol 58:1098-1105
108. Jaye DL, Waites KB, Parker B, Bragg SL, Moser SA (1998) Comparison of two rapid latex agglutination tests for detection of cryptococcal capsular polysaccharide. Am J Clin Pathol 109:634-641
109. Babady NE, Bestrom JE, Jespersen DJ, Jones MF, Beito EM, Binnicker MJ, Wengenack NL (2009) Evaluation of three commercial latex agglutination kits and a commercial enzyme immunoassay for the detection of cryptococcal antigen. Med Mycol 47:336-338
110. Mennink-Kersten MA, Donnelly JP, Verweij PE (2004) Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 4:349-57
111. Verdaguer V, Walsh TJ, Hope W, Cortez KJ (2007) Galactomannan antigen detection in the diagnosis of invasive aspergillosis. Expert Rev Mol Diagn 7:21-32
112. Thornton CR (2010) Detection of invasive aspergillosis. Adv Appl Microbiol 70:187-216
113. Chen SC, Kontoyiannis DP (2010) New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients. Curr Opin Infect Dis 23:567-77
114. Klont RR, Mennink-Kersten MA, Verweij PE (2004) Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis 39:1467-1474
115. Husain S, Clancy CJ, Nguyen MH, Swartzentruber S, Leather H, LeMonte AM, Durkin MM, Knox KS, Hage CA, Bentsen C, Singh N, Wingard JR, Wheat LJ (2008) Performance characteristics of the Platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fl uid. Clin Vaccine Immunol 15:1760-1763
116. Hage CA, Knox KS, Davis TE, Wheat LJ (2011) Antigen detection in bronchoalveolar lavage fl uid for diagnosis of fungal pneumonia. Curr Opin Pulm Med 17:167-171
117. Maertens J, Maertens V, Theunissen K, Meersseman W, Meersseman P, Meers S, Verbeken E, Verhoef G, Van Eldere J, Lagrou K (2009) Bronchoalveolar lavage fl uid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 49: 1688-1693
118. Hsu LY, Ding Y, Phua J, Koh LP, Chan DS, Khoo KL, Tambyah PA (2010) Galactomannan testing of bronchoalveolar lavage fl uid is use ful for diagnosis of invasive pulmonary aspergillosis in hematology patients. BMC Infect Dis 10:44-49
119. Nguyen MH, Jaber R, Leather HL, Wingard JR, Staley B, Wheat LJ, Cline CL, Baz M, Rand KH, Clancy CJ (2007) Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts. J Clin Microbiol 45:2787-2792
120. Steinbach WJ (2010) Invasive aspergillosis in pediatric patients. Curr Med Res Opin 26: 1779-1787
121. Verweij PE, Stynen D, Rijs AJ, de Pauw BE, Hoogkamp-Korstanje JA, Meis JF (1995) Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 33:1912-1914
122. Machetti M, Feasi M, Mordini N, Van Lint MT, Bacigalupo A, Latgé JP, Sarfati J, Viscoli C (1998) Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients. Bone Marrow Transplant 21:917-921
123. Fricker-Hidalgo H, Coltey B, Llerena C, Renversez JC, Grillot R, Pin I, Pelloux H, Pinel C (2010) Recombinant allergens combined with biological markers in the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis patients. Clin Vaccine Immunol 17:1330-1336
124. Tsagarakis N, Kentrou N, Margariti V, Malgarinou A, Maurea S, Tsagarakis I, Anastasakou E (2009) Anti-aspergillus antibodies and galactomannan antigen detection for serodiagnosis of aspergillosis. ECCMID Meeting. Abstract number: P905
125. Stone BA, Clarke AE (1992) Chemistry and biology of (1 → 3)-b -glucans. La Trobe University Press, Melbourne, Australia
126. Mennink-Kersten MA, Ruegebrink D, Verweij PE (2008) Pseudomonas aeruginosa as a cause of 1,3-b -D-glucan assay reactivity. Clin Infect Dis 46:1930-1931
127. Suzuki T, Ohno N, Saito K, Yadomae T (1992) Activation of the complement system by (1 → 3)-beta-D-glucans having different degrees of branching and different ultrastructures. J Pharmacobiodyn 15:277-285
128. Ohki M, Nakamura T, Morita T, Iwanaga S (1980) A new endotoxin sensitive factor associated with hemolymph coagulation system of horseshoe crab (Limulidae). FEBS Lett 120:217-20
129. Marty FM, Koo S (2009) Role of (1 → 3)-b -D-glucan in the diagnosis of invasive aspergillosis. Med Mycol 47(Suppl 1):S233-240
130. Maertens J, Meersseman W, Van Bleyenbergh P (2009) New therapies for fungal pneumonia. Curr Opin Infect Dis 22:183-190
131. Torelli R, Posteraro B, De Carolis E, De Pascale G, Caira M, Bello G, Antonelli M, Pagano L, Fadda G, Sanguinetti M (2011) Comparison of MycAssay Aspergillus test with galactomannan detection in bronchoalveolar lavage (BAL) fl uid samples of hematological and ICU patients. Poster 1941. 21st European society of clinical microbiology and infectious diseases meeting, Milan, Italy
132. Lehmann LE, Alvarez J, Hunfeld KP, Goglio A, Kost GJ, Louie RF, Raglio A, Regueiro BJ, Wissing H, Stüber F (2009) Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis. Crit Care Med 37:3085-3090
133. von Lilienfeld-Toal M, Lehmann LE, Raadts AD, Hahn-Ast C, Orlopp KS, Marklein G, Purr I, Cook G, Hoeft A, Glasmacher A, Stüber F (2009) Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J Clin Microbiol 47:2405-2410
134. Mancini N, Clerici D, Diotti R, Perotti M, Ghidoli N, De Marco D, Pizzorno B, Emrich T, Burioni R, Ciceri F, Clementi M (2008) Molecular diagnosis of sepsis in neutropenic patients with hematological malignancies. J Med Microbiol 57:601-604
135. Lamoth F, Jaton K, Prod'hom G, Senn L, Bille J, Calandra T, Marchetti O (2010) Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia. J Clin Microbiol 48:3510-3516
136. Dierkes C, Ehrenstein B, Siebig S, Linde HJ, Reischl U, Salzberger B (2009) Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 9:126-132
137. Louie RF, Tang Z, Albertson TE, Cohen S, Tran NK, Kost GJ (2008) Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med 36:1487-92
138. Westh H, Lisby G, Breysse F, Böddinghaus B, Chomarat M, Gant V, Goglio A, Raglio A, Schuster H, Stuber F, Wissing H, Hoeft A (2009) Multiplex real-time PCR and blood culture for identi fication of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect 15:544-51
139. Maubon D, Hamidfar-Roy R, Courby S, Vesin A, Maurin M, Pavese P, Ravanel N, Bulabois CE, Brion JP, Pelloux H, Timsit JF (2010) Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. J Infect 61:335-42
140. Yanagihara K, Kitagawa Y, Tomonaga M, Tsukasaki K, Kohno S, Seki M, Sugimoto H, Shimazu T, Tasaki O, Matsushima A, Ikeda Y, Okamoto S, Aikawa N, Hori S, Obara H, Ishizaka A, Hasegawa N, Takeda J, Kamihira S, Sugahara K, Asari S, Murata M, Kobayashi Y, Ginba H, Sumiyama Y, Kitajima M (2010) Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit. Crit Care 14:R159
141. Sachse S, Straube E, Lehmann M, Bauer M, Rußwurm S, Schmidt K-H (2009) Truncated hCGBP improves NAT-based detection of bacterial species in human samples. J Clin Microbiol 47:1050-1057
142. Kortgen A, Bloos F, Sachse S, Lehmann M, Straube E, Reinhart K, Bauer M (2009) Clinical relevance of fungal DNAemia detected by multiplex PCR in septic patients. 4th international congress of the german sepsis society, Weimar, Germany.
143. An assessment of the potential clinical utility of a new multiplex-PCR assay (Vyoo ®) in the management of ICU patients with sepsis. http://apps.who.int/trialsearch/Trial. aspx?TrialID=DRKS00000612 Accessed 19 July 2011
144. Wellinghausen N, Kochem AJ, Disqué C, Mühl H, Gebert S, Winter J, Matten J, Sakka SG (2009) Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. J Clin Microbiol 47:2759-65
145. Westh H, Lisby G, Breysse F, Böddinghaus B, Chomarat M, Gant V, Goglio A, Raglio A, Schuster H, Stuber F, Wissing H, Hoeft A (2009) Multiplex real-time PCR and blood culture for identi fication of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect 15:544-51
146. Maubon D, Hamidfar-Roy R, Courby S, Vesin A, Maurin M, Pavese P, Ravanel N, Bulabois CE, Brion JP, Pelloux H, Timsit JF (2010) Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. J Infect 61:335-42
147. Hauser PM, Bille J, Lass-Flörl C, Geltner C, Feldmesser M, Levi M, Patel H, Muggia V, Alexander B, Hughes M, Follett SA, Cui X, Leung F, Morgan G, Moody A, Perlin DS, Denning DW (2011) Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay. J Clin Microbiol 49:1872-8
148. White PL, Perry MD, Loef fl er J, Melchers W, Klingspor L, Bretagne S, McCulloch E, Cuenca-Estrella M, Finnstrom N, Donnelly JP, Barnes RA, European Aspergillus PCR Initiative (2010) Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens. J Clin Microbiol. 48:3753-3755
149. Klingspor L, Loef fl er J (2009) Aspergillus PCR formidable challenges and progress. Med Mycol 47(Suppl 1):S241-7
150. Mengoli C, Cruciani M, Barnes RA, Loef fl er J, Donnelly JP (2009) Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 9:89-96
151. Baldwin CD, Howe GB, Sampath R, Blyn LB, Matthews H, Harpin V, Hall TA, Drader JJ, Hofstadler SA, Eshoo MW, Rudnick K, Studarus K, Moore D, Abbott S, Janda JM, Whitehouse CA (2009) Usefulness of multilocus polymerase chain reaction followed by electrospray ionization mass spectrometry to identify a diverse panel of bacterial isolates. Diagn Microbiol Infect Dis 63:403-408